CHARITY REGISTRATION NUMBER: 1148463
BLOODRUN EVS
Unaudited Financial Statements
31 March 2025
TREMAINE
Chartered accountants 19 Tremaine Close
BLOODRUN EVS
Hartlepool TS27 3LE Financial Statements
Year ended 31 March 2025
| Page | |
|---|---|
| Trustees' annual report | 1 |
| Independent examiner's report to the trustees | 5 |
| Statement of financial activities | 6 |
| Statement of financial position | 7 |
| Notes to the financial statements | 8 |
09:48 on 18 July 2025
Draft Accounts
BLOODRUN EVS
Trustees' Annual Report
Year ended 31 March 2025
The trustees present their report and the unaudited financial statements of the charity for the year ended 31 March 2025.
| Reference and administrative details | ||
|---|---|---|
| Registered charity name | BLOODRUN EVS | |
| Charity registration number | 1148463 | |
| Principal office | Commerce House | |
| 1 Exchange Square | ||
| Middlesbrough | ||
| TS1 1DE | ||
| The trustees | ||
| M J Dixon | Chair | |
| K Bayne | Vice Chair | |
| G Dixon | Secretary | |
| M M Finegan | Treasurer | |
| J M Robson | (Appointed 24 November 2024) | |
| B Hodgson | (Appointed 24 November 2024) | |
| S A Khan | (Resigned 11 February 2025) | |
| M Dickinson | (Resigned 7 April 2024) | |
| P Spellman | (Resigned 3 April 2024) | |
| Independent examiner | Julie Todd Tremaine Chartered Certified Accountant |
19 Tremaine Close Hartlepool TS27 3LE
Structure, governance and management
The organisation is a registered charity, registered with the Charity Commission of England & Wales. The charity is governed by its constitution dated 7 August 2012.
Objectives and activities
The object of the charity is:
09:48 on 18 July 2025
Draft Accounts
1
Trustees' Annual Report (continued)
Year ended 31 March 2025
BLOODRUN EVS
To relieve sickness and protect public health by the provision of transport for urgently needed blood, drugs, human tissues and other medical requirements between hospitals, blood transfusion banks and other healthcare facilities.
To support human life by providing a free of charge transportation service to our local NHS and to other organisations with objectives similar to ours.
Achievements and Performance (Year ended 31 March 2025)
During the year the charity continued to deliver its core purpose: the free-of-charge, timecritical transport of blood, drugs, human tissue and other urgent medical items between hospitals, blood banks and healthcare facilities. We continued to see reduced demand compared with the higher activity levels experienced in 2022/23, reflecting our deliberate reevaluation of tasks undertaken to ensure that the charity’s resources (funds, vehicles and volunteer hours) are applied where they have the greatest impact and remain tightly aligned to our charitable objectives.
Service delivery and operational performance
Where possible, we continued to provide a 24-hour service for both North and South Tees Trusts . Operational demand has reduced year-on-year, but our requirement to respond quickly and reliably remains unchanged. Although our availability has been challenged at times by rota gaps, every call received was completed , supported by duty volunteers and adhoc availability where required. Alongside maintaining frontline delivery, we have reviewed services that risked mission creep and removed activities that were not the best use of charitable funds and volunteer time, improving overall efficiency and focus.
Volunteers, recruitment and resilience
Our volunteers remain the charity’s greatest asset. Over the last 12 months we have maintained a strong base of riders and drivers supporting both scheduled rotas and ad-hoc call-outs. However, we recognise that reliability of cover has been inconsistent at points during the year, with some shifts going unfilled. In response, we have advanced our recruitment programme by identifying bottlenecks, streamlining steps, and improving the onboarding journey while maintaining appropriate structure and safeguarding. We have also reviewed how we set expectations for volunteer contribution. A previous “3in3” approach (minimum commitment) became less effective after shift pattern changes; we are now moving toward a clearer commitment framework based on a 40-hour per quarter model inclusive of duty shifts, controller shifts, events and ad-hoc support. This is intended to increase predictability, strengthen resilience, and improve continuity of service for our NHS partners.
09:48 on 18 July 2025
Draft Accounts
2
BLOODRUN EVS
Trustees' Annual Report (continued)
Year ended 31 March 2025
Fundraising, awareness and community engagement
Fundraising activity continued throughout the year, including new locations and event types that broadened our reach. Awareness in the south of our operating area continues to improve, with further work planned to strengthen visibility and partnerships. Our Christmas raffle raised £3,827 this year, supported by generous prize donations and ticket sales from local businesses and individuals, and remains an important contributor to winter income and financial resilience.
Fleet development and key partnerships
Our fleet replacement strategy continues to progress well and remains ahead of the original schedule, supporting reliability and helping reduce running costs over time. During the year we added:
-
1 new motorcycle: BMW R 2510RT named HAMPTON
-
3 new cars: Hyundai Kona vehicles named MASON , DEBS and AARON (with AARON provided to the charity on a free-of-charge lease by SG Petch )
We also wish to record our sincere thanks to the Hampton by Hilton in Stockton for the generous use of their facilities in support of the charity. The HAMPTON motorcycle is named in recognition of that support and the positive partnership developed.
Financial stewardship supporting delivery
The year saw a strengthening of the charity’s overall financial position, giving the trustees greater confidence in sustainability and planned investment (including fleet replacement). Total income for the year was £88,721 (2024: £66,936), with expenditure of £46,752 (2024: £45,474). Net funds carried forward increased to £195,100 (2024: £153,131). Unrestricted reserves increased to £164,796 (2024: £118,295), including free reserves of £60,363 (2024: £46,477), providing improved flexibility to respond to operational needs.
Draft accounts 31.03.25
A key element of our governance is maintaining transparency and appropriate assurance. The accounts were subject to independent examination, and the independent examiner reported no matters of material concern arising from the examination.
Draft accounts 31.03.25
09:48 on 18 July 2025
Draft Accounts
3
Year ended 31 March 2025
BLOODRUN EVS
Trustees' Annual Report (continued)
Systems and continuous improvement
The charity’s operations are increasingly dependent on reliable digital systems (call handling, shift and volunteer management, fleet tracking, and compliance checks). These have remained resilient over the last 12 months. We continue to invest in process improvement, including the introduction of a digital receipt system to simplify auditing, reduce printing costs, and provide better real-time visibility of expenditure and queries.
Thanks
We remain wholly dependent on the dedication of our volunteers and supporters. The trustees thank everyone who covered shifts, responded to calls, attended events, donated, and represented the charity in the community—enabling us to continue delivering a lifesaving service for the Cleveland and North Yorkshire area.
Public Benefit
As we are all aware, our continued operations have significant benefit to the communities that we serve. Combining this with saving money for the NHS we should all be very proud of our ongoing achievements and the difference that we are making to the lives of those around us, every day.
When making operational decisions about the future activity of our charity, we always consider the benefit to the public. We will publish a "Summary of main activities undertaken" along with the Annual Accounts and Returns to the Charity Commission.
We will continue to consult with appropriate professionals, so we can continue to improve upon our Charities Commission compliance and governance matters during the coming year.
M J Dixon Trustee
09:48 on 18 July 2025
Draft Accounts
4
BLOODRUN EVS
Independent Examiner's Report to the Trustees of BLOODRUN EVS
Year ended 31 March 2025
I report to the trustees on my examination of the financial statements of BLOODRUN EVS ('the charity') for the year ended 31 March 2025.
Responsibilities and basis of report
As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity's financial statements carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or
-
the financial statements do not accord with those records; or
-
the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Julie Todd Tremaine Chartered Certified Accountant Independent Examiner
19 Tremaine Close Hartlepool TS27 3LE
09:48 on 18 July 2025
Draft Accounts
5
BLOODRUN EVS
Statement of Financial Activities
Year ended 31 March 2025
| Year ended 31 March 2025 | |||||
|---|---|---|---|---|---|
| 2025 | 2024 | ||||
| Unrestricted | Restricted | ||||
| funds | funds | Total funds | Total funds | ||
| Note | £ | £ | £ | £ | |
| Income and endowments | |||||
| Donations and legacies | 4 | 33,808 | 54,913 | 88,721 | 66,936 |
| �������� | �������� | �������� | �������� | ||
| Total income | 33,808 | 54,913 | 88,721 | 66,936 | |
| �������� | �������� | �������� | �������� | ||
| Expenditure | |||||
| Expenditure on charitable activities | 5 | 41,139 | – | 41,139 | 42,510 |
| Other expenditure | 6 | 5,613 | – | 5,613 | 2,964 |
| �������� | �������� | �������� | �������� | ||
| Total expenditure | 46,752 | – | 46,752 | 45,474 | |
| �������� | �������� | �������� | �������� | ||
| �������� | �������� | �������� | �������� | ||
| Net income | (12,944) | 54,913 | 41,969 | 21,462 | |
| �������� | �������� | �������� | �������� | ||
| Transfers between funds | 59,445 | (59,445) | – | – | |
| �������� | �������� | �������� | �������� | ||
| Net movement in funds | 46,501 | (4,532) | 41,969 | 21,462 | |
| Reconciliation of funds | |||||
| Total funds brought forward | 118,295 | 34,836 | 153,131 | 131,669 | |
| ��������� | �������� | ��������� | ��������� | ||
| Total funds carried forward | 164,796 | 30,304 | 195,100 | 153,131 | |
| ��������� | �������� | ��������� | ��������� |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
09:48 on 18 July 2025
Draft Accounts
6
BLOODRUN EVS
The notes on pages 8 to 13 form part of these financial statements.
Statement of Financial Position
31 March 2025
| 31 March 2025 | |||
|---|---|---|---|
| 2025 | 2024 | ||
| Note | £ | £ | |
| Fixed assets | |||
| Tangible fixed assets | 11 | 104,433 | 71,818 |
| Current assets | |||
| Debtors | 12 | 2,448 | 339 |
| Cash at bank and in hand | 108,239 | 83,725 | |
| ��������� | �������� | ||
| 110,687 | 84,064 | ||
| Creditors: amounts falling due within one year | 13 | 20,020 | 2,751 |
| ��������� | �������� | ||
| Net current assets | 90,667 | 81,313 | |
| ��������� | ��������� | ||
| Total assets less current liabilities | 195,100 | 153,131 | |
| ��������� | ��������� | ||
| Net assets | 195,100 | 153,131 | |
| ��������� | ��������� | ||
| Funds of the charity | |||
| Restricted funds | 30,304 | 34,836 | |
| Unrestricted funds | 164,796 | 118,295 | |
| ��������� | ��������� | ||
| Total charity funds | 14 | 195,100 | 153,131 |
| ��������� | ��������� |
These financial statements were approved by the board of trustees and authorised for issue on ........................, and are signed on behalf of the board by:
M J Dixon Trustee
09:48 on 18 July 2025
Draft Accounts
7
BLOODRUN EVS
The notes on pages 8 to 13 form part of these financial statements.
09:48 on 18 July 2025
Draft Accounts
8
Notes to the Financial Statements
BLOODRUN EVS
Year ended 31 March 2025
1. General information
The charity is a public benefit entity and a registered charity in England and Wales and is unincorporated. The address of the principal office is Commerce House, 1 Exchange Square, Middlesbrough, TS1 1DE.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Charities Act 2011.
- Accounting policies Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.
The financial statements are prepared in sterling, which is the functional currency of the entity. Going concern
There are no material uncertainties about the charity's ability to continue.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Fund accounting
Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes.
Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment.
Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds.
3. Accounting policies (continued)
Incoming resources
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:
- income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably.
09:48 on 18 July 2025
Draft Accounts
9
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2025
-
legacy income is recognised when receipt is probable and entitlement is established.
-
income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers.
-
income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
Resources expended
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
-
expenditure on raising funds includes the costs of all fundraising activities, events, noncharitable trading activities, and the sale of donated goods.
-
expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
-
other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
- Accounting policies (continued)
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses, except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activities.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
09:48 on 18 July 2025
Draft Accounts
10
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2025
Motor vehicles - 5% straight line Equipment - 25% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cashgenerating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the charity are assigned to those units.
4. Donations and legacies
| Unrestricted | Restricted | Total Funds | |||
|---|---|---|---|---|---|
| Funds | Funds | 2025 | |||
| £ | £ | £ | |||
| Donations | |||||
| Donations | 33,808 | 54,913 | 88,721 | ||
| �������� | �������� | �������� | |||
| Unrestricted | Restricted | Total Funds | |||
| Funds | Funds | 2024 | |||
| £ | £ | £ | |||
| Donations | |||||
| Donations | 32,835 | 34,101 | 66,936 | ||
| �������� | �������� | �������� | |||
| 5. | Expenditure on charitable activities by fund type | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2025 | Funds | 2024 | ||
| £ | £ | £ | £ | ||
| General fund | 41,139 | 41,139 | 42,510 | 42,510 | |
| �������� | �������� | �������� | �������� | ||
| 6. | Other expenditure | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2025 | Funds | 2024 | ||
| £ | £ | £ | £ | ||
| Loss on disposal of tangible fixed |
09:48 on 18 July 2025
Draft Accounts
11
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2025
| assets held for charity's own use | 5,613 | 5,613 | 2,964 | 2,964 | |
|---|---|---|---|---|---|
| ������� | ������� | ������� | ������� | ||
| 7. | Net income | ||||
| Net income is stated after charging/(crediting): | |||||
| 2025 | 2024 | ||||
| £ | £ | ||||
| Depreciation of tangible fixed assets | 5,837 | 5,243 | |||
| Loss on disposal of tangible fixed assets | 5,613 | 2,964 | |||
| ������� | ������� | ||||
| 8. | Independent examination fees | ||||
| 2024 | |||||
| 2025 | |||||
| £ | £ | ||||
| Fees payable to the independent examiner for: | |||||
| Independent examination of the financial statements | 200 | 200 | |||
| ���� | ���� | ||||
| 9. | Staff costs | ||||
| The average head count of employees during the | year was Nil (2024: Nil). | ||||
| No employee received employee benefits of | more than £60,000 during the year (2024: Nil). | ||||
| 10. | Trustee remuneration and expenses |
No remuneration or other benefits from employment with the charity or a related entity were received by the trustees.
11. Tangible fixed assets
| Tangible fixed assets | |||
|---|---|---|---|
| Motor | |||
| vehicles | Equipment | Total | |
| £ | £ | £ | |
| Cost | |||
| At 1 April 2024 | 115,959 | 1,186 | 117,145 |
| Additions | 54,665 | – | 54,665 |
| Disposals | (31,072) | – | (31,072) |
| ��������� | ������� | ��������� |
Draft Accounts 09:48 on 18 July 2025
12
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2025
| At 31 March 2025 | 139,552 | 1,186 | 140,738 | |
|---|---|---|---|---|
| ��������� | ������� | ��������� | ||
| Depreciation | ||||
| At 1 April 2024 | 44,764 | 563 | 45,327 | |
| Charge for the year | 5,681 | 156 | 5,837 | |
| Disposals | (14,859) | – | (14,859) | |
| ��������� | ������� | ��������� | ||
| At 31 March 2025 | 35,586 | 719 | 36,305 | |
| ��������� | ������� | ��������� | ||
| Carrying amount | ||||
| At 31 March 2025 | 103,966 | 467 | 104,433 | |
| ��������� | ������� | ��������� | ||
| At 31 March 2024 | 71,195 | 623 | 71,818 | |
| ��������� | ������� | ��������� | ||
| 12. | Debtors | |||
| 2024 | ||||
| 2025 | ||||
| £ | £ | |||
| Prepayments and accrued income | 836 | 339 | ||
| Other debtors | 1,612 | – | ||
| ������� | ���� | |||
| 2,448 | 339 | |||
| ������� | ���� | |||
| 13. | Creditors: amounts falling due within one year | |||
| 2024 | ||||
| 2025 | ||||
| £ | £ | |||
| Accruals and deferred income | – | 869 | ||
| Social security and other taxes | – | 1,882 | ||
| Other creditors | 20,020 | – | ||
| �������� | ������� | |||
| 20,020 | 2,751 | |||
| �������� | ������� |
09:48 on 18 July 2025
Draft Accounts
13
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2025
| Unrestricted funds | ||||||
|---|---|---|---|---|---|---|
| At | At 31 March | |||||
| 1 April | 2024 | Income | Expenditure | Transfers | 2025 | |
| £ | £ | £ | £ | £ | ||
| General funds | 118,295 | 33,808 | (46,752) | 59,445 | 164,796 | |
| �� | ������� | �������� | �������� | �������� | ��������� | |
| At | At 31 March | |||||
| 1 April | 2023 | Income | Expenditure | Transfers | 2024 | |
| £ | £ | £ | £ | £ | ||
| General funds | 107,761 | 32,835 | (45,474) | 23,173 | 118,295 | |
| �� | ������� | �������� | �������� | �������� | ��������� | |
| Restricted funds | ||||||
| At | At 31 March | |||||
| 1 April | 2024 | Income | Expenditure | Transfers | 2025 | |
| £ | £ | £ | £ | £ | ||
| New Bike Fund | 34,836 | 54,913 | – | (59,445) | 30,304 | |
| �� | ������ | �������� | ���� | �������� | �������� | |
| At | At 31 March | |||||
| 1 April | 2023 | Income | Expenditure | Transfers | 2024 | |
| £ | £ | £ | £ | £ | ||
| New Bike Fund | 23,908 | 34,101 | – | (23,173) | 34,836 | |
| �� | ������ | �������� | ���� | �������� | �������� | |
| Analysis of net assets between funds | ||||||
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2025 | ||||
| £ | £ | £ | ||||
| Intangible assets | 104,433 | – | 104,433 | |||
| Tangible fixed assets | – | – | – | |||
| Current assets | 80,383 | 30,304 | 110,687 | |||
| Creditors less than 1 year | (20,020) | – | (20,020) | |||
| ��������� | �������� | ��������� | ||||
| Net assets | 164,796 | 30,304 | 195,100 | |||
| ��������� | �������� | ��������� | ||||
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2024 |
- Analysis of net assets between funds
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2025
| £ | £ | £ | |
|---|---|---|---|
| Intangible assets | – | – | – |
| Tangible fixed assets | 71,818 | – | 71,818 |
| Current assets | 49,228 | 34,836 | 84,064 |
| Creditors less than 1 year | (2,751) | – | (2,751) |
| ��������� | �������� | ��������� | |
| Net assets | 118,295 | 34,836 | 153,131 |
| ��������� | �������� | ��������� |
Draft Accounts 09:48 on 18 July 2025 13 14. Analysis of charitable funds